| The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway N Furth, Y Aylon Cell Death & Differentiation 24 (9), 1488-1501, 2017 | 211 | 2017 |
| Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features S Arandkar, N Furth, Y Elisha, NB Nataraj, H van der Kuip, Y Yarden, ... Proceedings of the National Academy of Sciences 115 (25), 6410-6415, 2018 | 92 | 2018 |
| p53 shades of Hippo N Furth, Y Aylon, M Oren Cell Death & Differentiation 25 (1), 81-92, 2018 | 87 | 2018 |
| Down-regulation of LATS kinases alters p53 to promote cell migration N Furth, NB Ben-Moshe, Y Pozniak, Z Porat, T Geiger, E Domany, Y Aylon, ... Genes & development 29 (22), 2325-2330, 2015 | 75 | 2015 |
| p53 is essential for DNA methylation homeostasis in naive embryonic stem cells, and its loss promotes clonal heterogeneity A Tovy, A Spiro, R McCarthy, Z Shipony, Y Aylon, K Allton, E Ainbinder, ... Genes & development 31 (10), 959-972, 2017 | 66 | 2017 |
| Exposure of bipartite hydrophobic signal triggers nuclear quality control of Ndc10 at the endoplasmic reticulum/nuclear envelope N Furth, O Gertman, A Shiber, OS Alfassy, I Cohen, MM Rosenberg, ... Molecular biology of the cell 22 (24), 4726-4739, 2011 | 65 | 2011 |
| Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics V Fedyuk, N Erez, N Furth, O Beresh, E Andreishcheva, A Shinde, ... Nature biotechnology 41 (2), 212-221, 2023 | 40 | 2023 |
| LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state N Furth, IS Pateras, R Rotkopf, V Vlachou, I Rivkin, I Schmitt, D Bakaev, ... Life science alliance 1 (5), 2018 | 30 | 2018 |
| Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone Y Enuka, ME Feldman, A Chowdhury, S Srivastava, M Lindzen, ... Nucleic acids research 45 (22), 12681-12699, 2017 | 24 | 2017 |
| Single-cell epigenetic analysis reveals principles of chromatin states in H3. 3-K27M gliomas N Harpaz, T Mittelman, O Beresh, O Griess, N Furth, TM Salame, R Oren, ... Molecular cell 82 (14), 2696-2713. e9, 2022 | 22 | 2022 |
| TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein response R Isaac, I Goldstein, N Furth, N Zilber, S Streim, S Boura-Halfon, ... Cell Death & Differentiation 24 (1), 132-143, 2017 | 21 | 2017 |
| H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscape N Furth, D Algranati, B Dassa, O Beresh, V Fedyuk, N Morris, LH Kasper, ... Cell Reports 39 (7), 2022 | 18 | 2022 |
| It’s all in the combination: decoding the epigenome for cancer research and diagnostics N Furth, E Shema Current opinion in genetics & development 73, 101899, 2022 | 7 | 2022 |
| Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis Y Aylon, N Furth, G Mallel, G Friedlander, NB Nataraj, M Dong, O Hassin, ... Nature communications 13 (1), 7199, 2022 | 5 | 2022 |
| Unified platform for genetic and serological detection of COVID-19 with single-molecule technology N Furth, S Shilo, N Cohen, N Erez, V Fedyuk, AM Schrager, A Weinberger, ... PloS one 16 (7), e0255096, 2021 | 4 | 2021 |
| Tumor suppressor crosstalk: Hippo and p53 N Furth, N Bossel, Y Pozniak, T Geiger, E Domany, Y Aylon, M Oren European Journal of Cancer 1 (61), S50, 2016 | 2 | 2016 |
| miR‐4734 conditionally suppresses ER stress‐associated proinflammatory responses D Michael, E Feldmesser, C Gonen, N Furth, A Maman, O Heyman, ... FEBS letters 597 (9), 1233-1245, 2023 | 1 | 2023 |
| Multiplexed Detection of COVID-19 With Single-Molecule Technology N Furth, S Shilo, N Cohen, N Erez, V Fedyuk, AM Schrager, A Weinberger, ... | 1 | 2021 |
| An aurora A-Lats-aurora B axis ensures proper chromosome segregation N Furth, M Oren Cell Cycle 10 (18), 3055-3055, 2011 | 1 | 2011 |
| Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas D Algranati, R Oren, B Dassa, L Fellus-Alyagor, A Plotnikov, H Barr, ... bioRxiv, 2024.02. 05.578974, 2024 | | 2024 |
